celecoxib has been researched along with Glomerulonephritis in 3 studies
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with celecoxib increased cortical alpha(v) integrin mRNA expression 2." | 1.32 | Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression. ( Grabensee, B; Heering, P; Heise, G; Meyer-Kirchrath, J; Schrör, K; Waldner, C, 2003) |
"In celecoxib-treated PHN rats (group D) the mRNA expression of the EP3 and EP4 receptors was significantly reduced to 1." | 1.32 | COX-2 inhibition and prostaglandin receptors in experimental nephritis. ( Heering, P; Heise, G; Schrör, K; Waldner, C, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Waldner, C | 2 |
Heise, G | 2 |
Meyer-Kirchrath, J | 1 |
Schrör, K | 2 |
Grabensee, B | 1 |
Heering, P | 2 |
Zhang, L | 1 |
Bertucci, AM | 1 |
Smith, KA | 1 |
Xu, L | 1 |
Datta, SK | 1 |
3 other studies available for celecoxib and Glomerulonephritis
Article | Year |
---|---|
Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female | 2003 |
COX-2 inhibition and prostaglandin receptors in experimental nephritis.
Topics: Animals; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase I | 2003 |
Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Apoptosis; B-Lymphocytes; Celecoxib; Cycloox | 2007 |